Help Refer Outpatients Who May Need a Monoclonal Antibody for COVID-19

January 2021

Bamlanivimab will be the first med authorized to treat OUTPATIENTS with COVID-19.

This new monoclonal antibody blocks the virus that causes COVID-19...SARS-CoV-2...from entering cells.

Bamlanivimab is a single-dose IV infusion given over 1 hour.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Be Familiar With the First COVID-19 Vaccines
Insomnia Be Ready to Dispense Dayvigo or Lunesta for Insomnia
Sore Throat Watch Out for Mishaps With Sore Throat Meds
Med Safety Think Twice Before Putting an Rx on Hold
Dermatology Know How Options for Wrinkles Stack Up
Antidepressants Listen for Reports of Sexual Problems in Patients on Antidepressants
Calculations Make Pharmacy Math Fun, Easy, and ACCURATE
COVID-19 Help Refer Outpatients Who May Need a Monoclonal Antibody for COVID-19